Dose Finding Study of PB127 Ultrasound Contrast Agent in Healthy Volunteers and Patients With Coronary Artery Disease
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the dose of PB127 for detection and/or exclusion of
coronary artery disease when used with cardiac ultrasound. This study also evaluates the
safety of PB127.